Saturday 17 October 2026 Export SPOK’s income statement to Excel — free account

Spok Holdings, Inc.

SPOK Healthcare Health Information Services

Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024. In the quarter to June 2026, revenue fell 1.89%, EPS fell 9.09% and free cash flow fell 2.00%, each against the same quarter a year earlier. Dividend growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

10.61 0.12 −1.12%

Follow SPOK

Alert me

Market cap: $224.5M
P/E: 17.7×
Fwd P/E: 16.2×
Dividend yield: 11.8%
F-score: 6/9
Altman Z: 4.04
Beneish M: −2.76
Dividend safety: 32/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.47

Total sells 0.43

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	1	1	—	—	—	—
Sell	—	—	—	—	—	—	1	—	—	2	—	—

Insider Ownership 2.20%

Capital & Financial Ratios $m

Market Cap 224.45

Revenue 135.97

Net Income 12.24

Free Cash Flow 25.41

Net Debt (16.59)

Current Ratio 1.09

Debt/Equity 0.00

P/E ratio 17.68

Fwd P/E 16.20

P/S ratio 1.63

P/B ratio 1.59

Past 5Y EPS Growth —

This Y EPS Growth (12.00%)

Next Y EPS Growth 3.75%

Next Y revenue growth (0.29%)

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 47.73%

10-year low 10-year high

P/S against its own 10 years 39.62%

10-year low 10-year high

P/B against its own 10 years 72.50%

10-year low 10-year high

EV/Sales against its own 10 years 67.56%

10-year low 10-year high

EV/FCF against its own 10 years 11.44%

10-year low 10-year high

Dividends

Payout Ratio 2.16

Annual Dividend Rate 1.25

Annual Dividend Yield 11.78%

	total	individual payouts
2026	0.94	0.31 0.31 0.31
2025	1.25	0.31 0.31 0.31 0.31
2024	1.25	0.31 0.31 0.31 0.31
2023	1.25	0.31 0.31 0.31 0.31
2022	1.25	0.31 0.31 0.31 0.31
2021	0.50	0.13 0.13 0.13 0.13
2020	0.50	0.13 0.13 0.13 0.13
2019	0.50	0.13 0.13 0.13 0.13
2018	0.50	0.13 0.13 0.13 0.13
2017	0.50	0.13 0.13 0.13 0.13
2016	0.50	0.13 0.13 0.13 0.13 0.25

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	32	29	25	17
Receivables	23	22	23	23
Inventory	—	—	—	—
Other	1	1	1	1
	64	61	58	51

	2023	2024	2025	Q'26
Payables	6	6	4	4
ST’ Debt	—	—	—	—
Other	4	5	5	4
	48	49	49	46

Compound Annual Growth %

	10y	5y	3y
Sales	(3.01%)	(1.17%)	1.27%
Cash Flow	(3.62%)	2.04%	64.90%
Earnings	(14.96%)	0.00%	(10.10%)
Book Value	(7.80%)	(6.11%)	(5.07%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	33	35	—	—	—
’25	36	36	34	34	140
’24	35	34	35	34	138
’23	33	36	35	34	139
’22	34	34	34	33	135
’21	36	36	36	35	142
’20	37	36	38	37	148

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2	6	—	—	—
’25	2	7	8	12	29
’24	2	7	11	8	29
’23	3	9	3	12	26
’22	(5)	(1)	6	7	6
’21	1	3	6	(2)	8
’20	1	5	14	5	26

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2	6	—	—	—
’25	2	6	8	10	25
’24	1	7	10	8	26
’23	2	7	3	11	23
’22	(6)	(2)	5	5	3
’21	(3)	(1)	2	(5)	(7)
’20	(1)	1	11	2	11

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.09	0.20	—	—	—
’25	0.25	0.22	0.15	0.14	0.75
’24	0.21	0.17	0.18	0.18	0.73
’23	0.15	0.23	0.22	0.17	0.77
’22	(0.37)	0.10	0.15	1.21	1.09
’21	(0.12)	(0.04)	(0.13)	(0.86)	(1.14)
’20	(0.24)	0.20	0.16	(2.44)	(2.32)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	15.49	14.45	12.21	11.00	8.53	7.16	6.13	8.05	13.24	12.26	Analyst estimates 2026–2028 Powerpack
	High	21.85	22.60	16.25	17.25	12.33	12.86	10.14	18.05	18.14	19.31
People
People	Employees	587	596	596	638	602	563	376	384	410	421
	Revenue/emp, $m	0.31	0.29	0.28	0.25	0.25	0.25	0.36	0.36	0.34	0.33
Income, $m
Income, $m	Revenue	180	171	169	160	148	142	135	139	138	140
	Gross margin, %	82.93	83.40	80.88	79.67	79.12	77.16	78.99	80.51	79.15	78.68
	EBT	23	12	(2)	(13)	(22)	(27)	1	22	20	21
	EBT margin, %	12.79	6.75	(1.29)	(8.37)	(14.69)	(19.23)	0.74	16.06	14.55	15.35
	Net income	14	(15)	(1)	(11)	(44)	(22)	22	16	15	16
	Depreciation	13	12	11	18	34	26	4	4	4	3
Per share, $
Per share, $	Revenue	8.72	8.47	8.62	8.40	7.79	7.33	6.84	6.97	6.80	6.80
	Earnings	0.68	(0.76)	(0.08)	(0.56)	(2.32)	(1.14)	1.11	0.79	0.74	0.77
	Cash flow	1.82	0.77	0.52	0.61	1.37	0.41	0.33	1.31	1.43	1.41
	Capex	(0.30)	(0.46)	(0.30)	(0.25)	(0.77)	(0.79)	(0.19)	(0.17)	(0.16)	(0.18)
	Free cash flow	1.52	0.31	0.22	0.36	0.60	(0.37)	0.14	1.14	1.27	1.23
	Book value	15.65	14.38	13.96	13.10	10.54	8.95	8.70	8.21	7.65	7.12
	Shares, m	21	20	20	19	19	19	20	20	20	21
Valuation, ×
Valuation, ×	P/E	31.30	0.00	0.00	0.00	0.00	0.00	7.65	19.52	21.69	17.13
	P/S	2.48	1.81	1.54	1.46	1.43	1.27	1.24	2.21	2.36	1.94
	P/B	1.38	1.07	0.95	0.93	1.06	1.04	0.98	1.88	2.10	1.85
	EV/Sales	1.78	1.19	1.02	0.97	0.90	0.85	0.98	1.98	2.15	1.76
	EV/FCF	10.19	32.23	39.43	22.78	11.62	(16.71)	48.98	12.11	11.50	9.76
Cash, $m
Cash, $m	Operating cash flow	38	16	10	12	26	8	6	26	29	29
	Capex	(6)	(9)	(6)	(5)	(15)	(15)	(4)	(3)	(3)	(4)
	Free cash flow	31	6	4	7	11	(7)	3	23	26	25
Balance, $m
Balance, $m	Working capital	100	96	86	66	61	39	16	16	13	9
	Total debt	—	—	—	17	15	17	16	—	—	—
	Net debt	(126)	(107)	(87)	(77)	(79)	(60)	(36)	(32)	(29)	(25)
	Shareholders’ equity	322	291	275	250	201	174	171	164	155	146
Returns, %
Returns, %	ROA	3.61	(4.16)	(0.44)	(3.32)	(14.81)	(8.44)	8.87	6.64	6.73	7.50
	ROIC	7.05	3.65	(1.06)	(5.72)	(11.62)	(15.18)	0.11	10.07	9.44	10.17
	ROE	4.29	(5.00)	(0.52)	(4.10)	(19.62)	(11.85)	12.68	9.36	9.40	10.55

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CTEV Claritev Corporation	$404.4M	— (loss-making)	— (loss-making)	+6.59% (above 0%: growing)	n/m	+49.10% (above 0%: growing)	73.72%	9.09%	Compare
CARL Carlsmed, Inc.	$380.9M	— (loss-making)	— (loss-making)	+56.75% (above 0%: growing)	n/m	−6.84% (below 0%: shrinking)	76.78%	(58.27%)	Compare
CSLT Castlight Health, inc.	$332.4M	— (loss-making)	— (loss-making)	−0.86% (below 0%: shrinking)	n/m	+106.49% (above 0%: growing)	66.20%	(5.42%)	Compare
SPOK Spok Holdings, Inc.	$224.5M	17.7×	16.2×	−1.89% (below 0%: shrinking)	−9.09% (below 0%: shrinking)	−2.00% (below 0%: shrinking)	80.47%	15.50%
AMWL American Well Corporation	$210.6M	— (loss-making)	— (loss-making)	−26.59% (below 0%: shrinking)	n/m	+266.38% (above 0%: growing)	52.95%	(18.36%)	Compare
SY So-Young International Inc. Sponsored ADR	$198.9M	— (loss-making)	12.8×	+40.84% (above 0%: growing)	n/m	−798.37% (below 0%: shrinking)	44.11%	(8.64%)	Compare
OPRX OptimizeRx Corp.	$166.7M	35.4×	23.0×	−29.77% (below 0%: shrinking)	n/m	+89.86% (above 0%: growing)	76.51%	(0.43%)	Compare
DH Definitive Healthcare Corp.	$144.3M	— (loss-making)	— (loss-making)	−9.14% (below 0%: shrinking)	n/m	+21.44% (above 0%: growing)	73.45%	(12.23%)	Compare
HCAT Health Catalyst, Inc.	$135.5M	— (loss-making)	— (loss-making)	−12.68% (below 0%: shrinking)	n/m	+64.26% (above 0%: growing)	49.46%	(51.75%)	Compare
Median of peers	$204.7M	—	—	−5.00%	—	+56.68%	69.83%	(10.43%)

All 51 Health Information Services stocks →